170 related articles for article (PubMed ID: 34215278)
1. Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol.
Zhang D; Han M; Zhou M; Liu M; Li Y; Xu B; Zhang A
Reprod Biol Endocrinol; 2021 Jul; 19(1):99. PubMed ID: 34215278
[TBL] [Abstract][Full Text] [Related]
2. GnRH antagonist alters the migration of endometrial epithelial cells by reducing CKB.
Chen Q; Fan Y; Zhou X; Yan Z; Kuang Y; Zhang A; Xu C
Reproduction; 2020 May; 159(6):733-743. PubMed ID: 32213653
[TBL] [Abstract][Full Text] [Related]
3. Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol.
Xu B; Zhou M; Wang J; Zhang D; Guo F; Si C; Leung PCK; Zhang A
Hum Reprod; 2018 Jul; 33(7):1270-1280. PubMed ID: 29897458
[TBL] [Abstract][Full Text] [Related]
4. Effects of GnRH antagonist on endometrial protein profiles in the window of implantation.
Meng Y; Guo Y; Qian Y; Guo X; Gao L; Sha J; Cui Y; Chian RC; Liu J
Proteomics; 2014 Oct; 14(20):2350-9. PubMed ID: 25065715
[TBL] [Abstract][Full Text] [Related]
5. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects.
Haouzi D; Assou S; Dechanet C; Anahory T; Dechaud H; De Vos J; Hamamah S
Biol Reprod; 2010 Apr; 82(4):679-86. PubMed ID: 20042535
[TBL] [Abstract][Full Text] [Related]
6. GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression.
Xu DF; Liu PP; Fan L; Xie Q; Zhang ZQ; Wang LQ; Wu QF; Tan J
Reprod Biol Endocrinol; 2022 Feb; 20(1):29. PubMed ID: 35120552
[TBL] [Abstract][Full Text] [Related]
7. GnRH antagonists may affect endometrial receptivity.
Rackow BW; Kliman HJ; Taylor HS
Fertil Steril; 2008 May; 89(5):1234-1239. PubMed ID: 18410932
[TBL] [Abstract][Full Text] [Related]
8. Association of controlled ovarian hyperstimulation treatment with down-regulation of key regulators involved in embryonic implantation in mice.
Xiong M; Zhang H; Jin L; Ai J; Huang Z; Zhu G
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):535. PubMed ID: 21823018
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium.
Chen Q; Yu F; Li Y; Zhang AJ; Zhu XB
Drug Des Devel Ther; 2019; 13():1855-1863. PubMed ID: 31239640
[No Abstract] [Full Text] [Related]
10. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
[TBL] [Abstract][Full Text] [Related]
11. Endometrial HOXA10 expression after controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone.
Taylor HS; Daftary GS; Selam B
Fertil Steril; 2003 Sep; 80 Suppl 2():839-43. PubMed ID: 14505762
[TBL] [Abstract][Full Text] [Related]
12. HOXA10 protein expression in the endometrium of normally menstruating women after receiving GnRH antagonist.
Sirayapiwat P; Triratanachat S; Tantbirojn P; Ruangvejvorachai P; Suwajanakorn S
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):321-5. PubMed ID: 23541416
[TBL] [Abstract][Full Text] [Related]
13. Endometrial but not Ovarian Response is Associated With Clinical Outcomes and can be Improved by Prolonged Pituitary Downregulation in Patients With Thin and Medium Endometrium.
Song J; Sun X; Qian K
Reprod Sci; 2019 Nov; 26(11):1409-1416. PubMed ID: 30501453
[TBL] [Abstract][Full Text] [Related]
14. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
15. Stop GnRH-Agonist Combined with Multiple-Dose GnRH-Antagonist for Patients with Elevated Peak Serum Progesterone Levels Undergoing Ovarian Stimulation for IVF: A Proof of Concept.
Orvieto R; Kirshenbaum M; Galiano V; Zilberberg E; Haas J; Nahum R
Gynecol Obstet Invest; 2020; 85(4):357-361. PubMed ID: 32580194
[TBL] [Abstract][Full Text] [Related]
16. A soluble molecule secreted by human blastocysts modulates regulation of HOXA10 expression in an epithelial endometrial cell line.
Sakkas D; Lu C; Zulfikaroglu E; Neuber E; Taylor HS
Fertil Steril; 2003 Nov; 80(5):1169-74. PubMed ID: 14607569
[TBL] [Abstract][Full Text] [Related]
17. Effect of GnRH analogues on apoptosis and expression of Bcl-2, Bax, Fas and FasL proteins in endometrial epithelial cell cultures from patients with endometriosis and controls.
Bilotas M; Barañao RI; Buquet R; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2007 Mar; 22(3):644-53. PubMed ID: 17092985
[TBL] [Abstract][Full Text] [Related]
18. Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes.
Detti L; Ambler DR; Yelian FD; Kruger ML; Diamond MP; Puscheck EE
J Assist Reprod Genet; 2008 May; 25(5):177-81. PubMed ID: 18461435
[TBL] [Abstract][Full Text] [Related]
19. Metformin Regulates Key MicroRNAs to Improve Endometrial Receptivity Through Increasing Implantation Marker Gene Expression in Patients with PCOS Undergoing IVF/ICSI.
Zhai J; Yao GD; Wang JY; Yang QL; Wu L; Chang ZY; Sun YP
Reprod Sci; 2019 Nov; 26(11):1439-1448. PubMed ID: 30599813
[TBL] [Abstract][Full Text] [Related]
20. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
